Marker Therapeutics Inc.
MRKR | NASDAQ
$1.20
+$0.02 (+1.69%)
At close: Sep 21, 2026, 4:00 PM ET
$1.20
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Market Data
Market Cap $19.67M
Enterprise Value $8.68M
Beta 1.53
Average Volume 64.78K
Shares Outstanding (Diluted) 19.31M
Shares Change YoY 38.39%
Institutional Ownership 20.21%
Exchange NASDAQ
ISIN US57055L2060
Price Performance
Price Change 1M -16.7%
Price Change 3M -12.4%
Price Change 6M -10.4%
Price Change YTD -22.1%
Price Change 1Y 33.3%
Price Change 3Y -75.7%
Price Change 5Y -93.3%
1M CAGR (ann.) 5.4%
1Y CAGR (ann.) 24.2%
5Y CAGR (ann.) -42.6%
All-Time CAGR -44.9%
Valuation
PE Ratio -2.55
Forward PE N/A
PEG Ratio -0.02
Forward PEG -0.05
PS Ratio 16.23
Forward PS 1.00
PB Ratio 1.64
P/FCF Ratio -2.05
P/Adj. FCF Ratio -1.95
P/OCF Ratio -2.35
EV/Sales 7.04
EV/EBIT -1.26
EV/EBITDA -0.91
EV/FCF -0.89
Earnings Yield -39.2%
FCF Yield -48.8%
Adj. FCF Yield -51.4%
Financial Health
Net Cash $11.33M
Total Debt $0
Cash & Short-Term Investments $11.33M
Total Assets $14.59M
Current Ratio 6.03
Quick Ratio 6.03
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt N/A
Interest Coverage 0.00
Altman Z-Score -40.15
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin -320.8%
Operating Profit Margin -869.0%
EBITDA Margin -707.5%
Net Profit Margin -706.2%
FCF Margin -791.3%
Adj. FCF Margin -833.4%
SBC / Revenue 27.6%
SBC Impact (per share) -5.3%
Returns
Return on Assets -59.7%
Return on Equity -57.0%
Return on Invested Capital -87.9%
Return on Capital Employed -88.1%
Return on Tangible Assets -59.7%
Historical Growth (CAGR)
Revenue CAGR 3Y -31.0%
Revenue CAGR 5Y -5.5%
Revenue CAGR 10Y 25.7%
EPS CAGR 3Y 34.9%
EPS CAGR 5Y 48.2%
EPS CAGR 10Y 26.8%
FCF CAGR 3Y 5.4%
FCF CAGR 5Y 32.1%
FCF CAGR 10Y 0.3%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y 166.7%
Revenue Growth Next 3Y 411.1%
Earnings Date N/A
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Cash Flow
Operating Cash Flow $-9.76M
Free Cash Flow $-9.76M
Adj. Free Cash Flow $-10.28M
FCF Per Share -$0.51
OCF Per Share -$0.51
OCF/S Ratio -791.3%
Income Statement
Revenue $1.23M
Gross Profit $-3.96M
Operating Income $-10.71M
EBITDA $-9.52M
Net Income $-8.71M
EPS (Diluted) -$0.47
Revenue / Employee $246.59K
Profit / Employee $-1.74M
Employees 5
Add to Watchlist
Select watchlists to add or remove MRKR